#USA #Wilmington #Chemo Mouthpiece #Chemomouthpiece #Zeal Pharmacy

Chemomouthpiece, LLC and Zeal Specialty Pharmacy Announce New Partnership

Chemomouthpiece, LLC, a dedicated player in medical innovation focusing on supportive oncology care, recently declared a noteworthy collaboration with Zeal Specialty Pharmacy. This partnership aims to enhance patient access to the Chemo Mouthpiece® oral cooling device, which is crucial for alleviating the side effects of chemotherapy.

Enhancing Patient Support System

The partnership is designed to provide comprehensive support to oncology practices and their patients. Through this alliance, Zeal Specialty Pharmacy will streamline processes related to prescribing the Chemo Mouthpiece. This includes coordinating prescriptions, investigating benefits, assisting with prior authorizations, and facilitating patient onboarding processes. Not only does this lead to a more structured approach to patient care, but it also aims to provide patients early access to the Chemo Mouthpiece before their chemotherapy starts.

Understanding Chemo Mouthpiece®

The Chemo Mouthpiece® has received FDA 510(k) clearance. It works by cooling the oral mucosa, consequently reducing the incidence and severity of oral mucositis, a debilitating side effect that affects many undergoing treatment for cancer. Oral mucositis, a condition where inflammation and ulceration occur in the oral cavity, can severely limit a patient's ability to eat, speak, and continue their treatment regimen. The implications of untreated mucositis can lead to increased healthcare utilization, including more hospital visits and medication requirements.

Recent clinical trials published in the journal Supportive Care in Cancer revealed significant benefits of using the Chemo Mouthpiece. The results indicated a 46% reduction in reported oral pain among patients who utilized the device during chemotherapy. Additionally, there was a noteworthy 68% decrease in the use of opioid analgesics, highlighting the Chemo Mouthpiece's potential to improve the quality of life for cancer patients.

Frank Jacobucci, Chief Commercial Officer at Chemomouthpiece, stated, "Our mission has always been to help patients better manage one of the most painful and disruptive side effects of chemotherapy treatment. Through our partnership with Zeal, we aim to help more patients access the Chemo Mouthpiece early in their treatment journey."

Zeal Specialty Pharmacy's Role

Located in Pittsburgh, PA, Zeal Specialty Pharmacy stands out for its technology-driven approach to pharmacy services, particularly focused on rare and complex conditions. The collaboration with Chemomouthpiece reaffirms Zeal's commitment to enhancing the experience of oncology patients. Jonathan Ogurchak, CEO and Co-Founder of Zeal, remarked, “Oral mucositis is one of the most painful and under-supported side effects of chemotherapy. Partnering with Chemomouthpiece allows us to help patients manage this condition efficiently.”

Conclusion

This partnership marks a significant step forward in the provision of oncology care, showcasing how collaboration between medical device companies and specialty pharmacies can help streamline processes while enhancing patient care. Together, Chemomouthpiece, LLC and Zeal Specialty Pharmacy are paving the way for improved healthcare pathways that prioritize patient needs. For health care providers interested in prescribing the Chemo Mouthpiece or receiving more information about the patient access support, details are available at Chemomouthpiece's website.